NCT01444651View on ClinicalTrials.gov

A Trial of Tadalafil and Glycemic Traits

PHASE3CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Cardiovascular DiseaseInsulin ResistanceGlucose IntoleranceObesity
Interventions
DRUG

Tadalafil

20 mg Tadalafil taken once a day for 3 months

DRUG

Placebo

Placebo tablet taken by mouth once a day for 3 months

Trial Locations (1)

Unknown

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Thomas J. Wang, MD

OTHER

NCT01444651 - A Trial of Tadalafil and Glycemic Traits | Biotech Hunter | Biotech Hunter